Ceroi, A., Masson, D., Roggy, A., Roumier, C., Chague, C., Gauthier, T., . . . Saas, P. (2016). LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis. Blood, 128(23), 2694. https://doi.org/10.1182/blood-2016-06-724807
Chicago Style (17th ed.) CitationCeroi, Adam, et al. "LXR Agonist Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm Restores Cholesterol Efflux and Triggers Apoptosis." Blood 128, no. 23 (2016): 2694. https://doi.org/10.1182/blood-2016-06-724807.
MLA (9th ed.) CitationCeroi, Adam, et al. "LXR Agonist Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm Restores Cholesterol Efflux and Triggers Apoptosis." Blood, vol. 128, no. 23, 2016, p. 2694, https://doi.org/10.1182/blood-2016-06-724807.